我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Voriconazole Eye Drops: A Revolutionary Approach for Treating Fungal Keratitis

Naomi Morgan

Fungal keratitis is a severe and potentially sight-threatening infection of the cornea caused by various species of fungi. It poses a significant challenge to ophthalmologists due to its aggressive nature and resistance to conventional treatments. In recent years, Voriconazole eye drops have emerged as a promising therapy for fungal keratitis, offering improved efficacy and better patient outcomes. This article explores the use of Voriconazole eye drops as a treatment option for fungal keratitis, highlighting its mechanism of action, effectiveness, and safety profile. Voriconazole is a novel antifungal agent with excellent broad spectrum activity commercially available for oral and intravenous administration. The purpose of this study was to prepare ophthalmic formulation of hydroxypropyl beta cyclodextrin based voriconazole containing benzalkonium chloride BAK and EDTA with or without viscosity modifiers and study its permeation characteristics through freshly excised goat cornea.